CLEVELAND, Nov. 30, 2016 /PRNewswire/ -- GenomOncology today announced the appointment of Joshua F. Coleman, M.D., as Vice President of Medical Affairs.
Dr. Coleman will oversee clinical content development and curation of scientific evidence, enhancing the company's proprietary knowledge-enabled platform. The GenomOncology software suite empowers molecular pathologists with a seamless workflow for the interpretation of genetic sequencing data and clinical decision support, from quality control through reporting.
Prior to joining GenomOncology, Dr. Coleman held an appointment of assistant professor at The Ohio State University College of Medicine and practiced molecular genetic pathology in the James Cancer Hospital Molecular Laboratory. Dr. Coleman completed medical school at Case Western Reserve University, followed by residency in Anatomic and Clinical Pathology at the Cleveland Clinic. He is fellowship-trained and board-certified in Hematopathology and Molecular Genetic Pathology.
"Adding a pathologist to our team has been a long-time goal, and we're confident that with his clinical expertise, Josh will add tremendous value to the direction of our Precision Medicine Portfolio," notes CEO and Founder Manuel Glynias.
Dr. Coleman also brings his strong desire for innovation, drawing upon insights from machine learning and information theory. "Increasingly, the practice of pathology is becoming the practice of data science," states Dr. Coleman. "My driving interest is to extract meaning and present it in the most clear and efficient manner to pathologists, oncologists, and patients. There is a delicate art to communicating just the right information at the right time, but I believe that this is something we can perfect with advanced informatics tools."
GenomOncology is a healthcare technology company enabling precision medicine by transforming genomic data into actionable information.
Baiju Parikh, VP Sales and Marketing
1375 East 9th Street, Suite 1120
Cleveland, OH 44114